fromIPWatchdog.com | Patents & Intellectual Property Law
1 month agoCAFC Overturns $39 Million Jury Verdict, Finds Allergan Hair Loss Patent Invalid for Lack of Written Description
The U.S. Court of Appeals for the Federal Circuit (CAFC) on Tuesday issued a precedential decision in Duke University v. Sandoz Inc., reversing a judgment from the U.S. District Court for the District of Colorado and finding claim 30 of U.S. Patent No. 9,579,270 invalid for lacking an adequate written description. The ruling overturns a $39 million jury verdict finding that Sandoz Inc. infringed the patent owned by Duke University and Allergan Sales, LLC, which covers the eyelash growth drug, LATISSE.
Intellectual property law